Caribou Biosciences, Inc. (CRBU)
1.645
-0.12
(-6.53%)
USD |
NASDAQ |
Aug 26, 16:00
1.645
0.00 (0.00%)
After-Hours: 18:37
Caribou Biosciences Max Drawdown (5Y) : 97.58% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 97.58% |
| June 30, 2026 | 97.58% |
| May 31, 2026 | 97.58% |
| April 30, 2026 | 97.58% |
| March 31, 2026 | 97.58% |
| February 28, 2026 | 97.58% |
| Date | Value |
|---|---|
| January 31, 2026 | 97.58% |
| December 31, 2025 | 97.58% |
| November 30, 2025 | 97.58% |
| October 31, 2025 | 97.58% |
| September 30, 2025 | 97.58% |
| August 31, 2025 | 97.58% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Intellia Therapeutics, Inc. | 96.45% |
| Vir Biotechnology, Inc. | 94.85% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -63.74 |
| Beta (5Y) | 2.377 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.11% |
| Historical Sharpe Ratio (5Y) | -0.4805 |
| Historical Sortino (5Y) | -1.149 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.35% |